Chang, Rachel S.
Shing, Jaimie Z.
Erves, Jennifer C.
Du, Liping
Koyama, Tatsuki
Deppen, Stephen
Rentuza, Alyssa B.
McAfee, Caree
Stroebel, Christine
Cates, Janet
Harnack, Lora
Andrews, David
Bramblett, Robert
Hull, Pamela C.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Measurement of provider fidelity to immunization guidelines: a mixed-methods study on the feasibility of documenting patient refusals of the human papillomavirus vaccine
https://doi.org/10.1186/s12911-022-02083-2
Funding for this research was provided by:
National Institutes of Health (R01CA207401, R01CA207401, R01CA207401, R01CA207401, R01CA207401, R01CA207401, R01CA207401, R01CA207401, R01CA207401, R01CA207401, R01CA207401, R01CA207401, R01CA207401, R01CA207401)
Article History
Received: 17 November 2022
Accepted: 13 December 2022
First Online: 22 December 2022
Declarations
:
: This study was approved by the Institutional Review Board of Vanderbilt University Medical Center as the Single IRB of Record, Protocol #171793). All methods were performed in accordance with the Declaration of Helsinki. Informed consent was obtained from all subjects.
: Not applicable.
: All authors have reported that they have no competing interests.